Table 2.
Variable | Controls (n = 15) | BE (n = 41) | EAC (n = 59) |
---|---|---|---|
Gender (male) | 3 (20 %) | 31 (76 %) | 53 (90 %) |
Age (years, mean ± SD and range) | 39.5 ± 14.7 (19–68) | 59.2 ± 11.7 (35–81) | 65.8 ± 10.8 (42–85) |
Barrett length (mean and range) | na | C3M4 (C0M2–C10M11) | C5M8 (C0M2–C14M14) |
Tumor stage (T) | |||
1 | na | na | 6 (10 %) |
2 | 10 (17 %) | ||
3 | 36 (61 %) | ||
4 | 1 (2 %) | ||
X (unknown) | 6 (10 %) | ||
Lymph node status (N) | |||
0 | na | na | 22 (37 %) |
1 | 24 (41 %) | ||
2 | 6 (10 %) | ||
3 | 1 (2 %) | ||
4 | 0 (0 %) | ||
X | 6 (10 %) | ||
Metastasis (M) | |||
0 | na | na | 6 (10 %) |
1 | 8 (14 %) | ||
X | 45 (76 %) | ||
Body mass index (mean ± SD) | 24.5 ± 4.0 | 25.6 ± 2.6 | 25.3 ± 2.9 |
Current smokers | 3 | 6 | 4 |
Previous smokers | 3 | 4 | 7 |
Non-smokers | 9 | 6 | 6 |
Unknown | 25 | 42 |
BE Barrett’s esophagus, EAC esophageal adenocarcinoma, CM circumference length, maximum length